Vienna, Austria

ESTRO 2025

Local time in host city

Programme

6 Sessions
Saturday
May 03
08:00 - 08:40
Lehar 1-3
Hugo Palmans, Austria
Teaching Lecture
Physics
Dosimetry & QA / FLASH
Saturday
May 03
09:00 - 10:00
Business 1-2
Bruno Fionda, Italy;
Clare David, United Kingdom
Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will be recorded and made available via the online platform and mobile app.
Mini-Orals
Clinical
FLASH / Skin / Soft Tissue
Saturday
May 03
11:40 - 12:40
Plenary Hall
Matthias Guckenberger, Switzerland
Symposium
Interdisciplinary
Breast / CNS / Dosimetry & QA / FLASH / SBRT / Urology
Saturday
May 03
13:30 - 14:00
Business 1-2
Meet & Greet sessions provide journey participants with the opportunity to network and to meet ESTRO focus group representatives who developed these journeys. Registration for Meet & Greet sessions is required via the Journeys tab on the ESTRO 2025 website.
Meet & Greet
FLASH
Saturday
May 03
17:00 - 18:00
Brahms
Claudia Rübe, Germany;
François Paris, France
Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.
Proffered Papers
Radiobiology
FLASH / Skin / Urology
Sunday
May 04
08:00 - 08:40
Brahms
Pierre Montay-Gruel, Belgium
Over a decade ago, FLASH radiotherapy emerged in the field of radiation oncology with the promise of widening the therapeutic window. While the number of supporting preclinical studies has grown exponentially, technological and biological challenges have slowed its clinical translation, resulting in only a limited number of early-phase clinical trials currently underway. This panel discussion brings together three multidisciplinary experts with experience in clinical translation. They will explore why this promising technique has not yet been widely adopted in clinical practice and discuss the necessary steps and actions to ensure the safe and successful translation of FLASH radiotherapy into clinical use. The discussion will also highlight the importance of veterinary clinical trials and preclinical biology studies in bridging the gap from bench to bedside, ensuring that FLASH radiotherapy's potential is fully realized in both human and veterinary medicine.
Panel Discussion
Radiobiology
Dosimetry & QA / FLASH / Skin
+(event:"a7b130b7-ab19-ef11-9f89-000d3ab97e6f")